Skip Navigation


Human Molecular Genetics Advance Access originally published online on March 3, 2004
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Supplementary Material
Right arrow All Versions of this Article:
13/8/851    most recent
ddh102v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (6)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Oravecz-Wilson, K. I.
Right arrow Articles by Ross, T. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Oravecz-Wilson, K. I.
Right arrow Articles by Ross, T. S.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Human Molecular Genetics, 2004, Vol. 13, No. 8 851-867
DOI: 10.1093/hmg/ddh102
Human Molecular Genetics, Vol. 13, No. 8 © Oxford University Press 2004; all rights reserved

Huntingtin Interacting Protein 1 mutations lead to abnormal hematopoiesis, spinal defects and cataracts

Katherine I. Oravecz-Wilson1, Mark J. Kiel1,2, Lina Li1, Dinesh S. Rao1, Djenann Saint-Dic1, Priti D. Kumar1, Melissa M. Provot1, Kurt D. Hankenson3, Venkat N. Reddy4, Andrew P. Lieberman5, Sean J. Morrison1,2 and Theodora S. Ross1,*

1Department of Internal Medicine, 2Howard Hughes Medical Institute, 3Orthopaedic Research Laboratory, 4Kellogg Eye Center and 5Department of Pathology, University of Michigan Medical School, Ann Arbor, MI 48109, USA

Received December 31, 2003; Accepted February 16, 2004

Huntingtin Interacting Protein 1 (HIP1) binds clathrin and AP2, is overexpressed in multiple human tumors, and transforms fibroblasts. The function of HIP1 is unknown although it is thought to play a fundamental role in clathrin trafficking. Gene-targeted Hip1–/– mice develop premature testicular degeneration and severe spinal deformities. Yet, although HIP1 is expressed in many tissues including the spleen and bone marrow and was part of a leukemogenic translocation, its role in hematopoiesis has not been examined. In this study we report that three different mutations of murine Hip1 lead to hematopoietic abnormalities reflected by diminished early progenitor frequencies and resistance to 5-FU-induced bone marrow toxicity. Two of the Hip1 mutant lines also display the previously described spinal defects. These observations indicate that, in addition to being required for the survival/proliferation of cancer cells and germline progenitors, HIP1 is also required for the survival/proliferation of diverse types of somatic cells, including hematopoietic progenitors.

* To whom correspondence should be addressed. Tel: +1 7346155509; Email: tsross{at}umich.edu


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Cancer Res.Home page
C. W. Graves, S. T. Philips, S. V. Bradley, K. I. Oravecz-Wilson, L. Li, A. Gauvin, and T. S. Ross
Use of a Cryptic Splice Site for the Expression of Huntingtin Interacting Protein 1 in Select Normal and Neoplastic Tissues
Cancer Res., February 15, 2008; 68(4): 1064 - 1073.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
J. A. Parker, M. Metzler, J. Georgiou, M. Mage, J. C. Roder, A. M. Rose, M. R. Hayden, and C. Neri
Huntingtin-Interacting Protein 1 Influences Worm and Mouse Presynaptic Function and Protects Caenorhabditis elegans Neurons against Mutant Polyglutamine Toxicity
J. Neurosci., October 10, 2007; 27(41): 11056 - 11064.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S. V. Bradley, M. R. Smith, T. S. Hyun, P. C. Lucas, L. Li, D. Antonuk, I. Joshi, F. Jin, and T. S. Ross
Aberrant Huntingtin Interacting Protein 1 in Lymphoid Malignancies
Cancer Res., September 15, 2007; 67(18): 8923 - 8931.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
S. V. Bradley, T. S. Hyun, K. I. Oravecz-Wilson, L. Li, E. I. Waldorff, A. N. Ermilov, S. A. Goldstein, C. X. Zhang, D. G. Drubin, K. Varela, et al.
Degenerative phenotypes caused by the combined deficiency of murine HIP1 and HIP1r are rescued by human HIP1
Hum. Mol. Genet., June 1, 2007; 16(11): 1279 - 1292.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S. V. Bradley, K. I. Oravecz-Wilson, G. Bougeard, I. Mizukami, L. Li, A. J. Munaco, A. Sreekumar, M. N. Corradetti, A. M. Chinnaiyan, M. G. Sanda, et al.
Serum Antibodies to Huntingtin Interacting Protein-1: A New Blood Test for Prostate Cancer
Cancer Res., May 15, 2005; 65(10): 4126 - 4133.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
T. S. Hyun, L. Li, K. I. Oravecz-Wilson, S. V. Bradley, M. M. Provot, A. J. Munaco, I. F. Mizukami, H. Sun, and T. S. Ross
Hip1-related Mutant Mice Grow and Develop Normally but Have Accelerated Spinal Abnormalities and Dwarfism in the Absence of HIP1
Mol. Cell. Biol., May 15, 2004; 24(10): 4329 - 4340.
[Abstract] [Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.